(ISPH) Inspire Pharmaceuticals, Inc. – Bull of the Day

November 9th, 2009

Inspire Pharmaceuticals, Inc. (ISPH) is a specialty pharmaceutical company focused on the development and commercialization of treatments for respiratory and ophthalmologic disorders.

Currently, the company has three products on the market and a robust pipeline. We see strong top line growth from 2009 and beyond. Inspire just reported positive phase III data of

Denufosol for CF. The company has a strong collaborative alliance with Allergan Pharmaceuticals for key products that treat dry eyes and allergic conjunctivitis.

Current price is attractive. We maintain our Outperform rating on shares of Inspire with a price target of $7.00.

Zacks Investment Research
View original at: Zacks.com News Feed

More on this topic (What's this?)
155% upside = "Neutral"? (ISPH) (AlphaNinja, 9/29/09)
Read more on Inspire Pharmaceuticals at Wikinvest


Similar Posts: | | Drug Manufacturers - Other | Healthcare

RSS feeds: Inspire Pharmaceuticals Inc | ISPH | Drug Manufacturers - Other | Healthcare |

Other Posts by vitalstocks | RSS Feed for this author

Post a Response

You must be logged in to post a comment.